Literature DB >> 15183115

Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.

Dominique Delmeire1, Daisy Flamez, Karen Moens, Simon A Hinke, Chris Van Schravendijk, Daniel Pipeleers, Frans Schuit.   

Abstract

Glucagon-like peptide-1 (7-36) amide (GLP-1) and glucose-dependent insulinotropic peptide (GIP) potentiate glucose-induced insulin release when present at the time of nutrient stimulation. This study examines whether they can also influence rat beta cell responsiveness to subsequent stimulations. When rat beta cells were cultured for 24 h with 1 nM GLP-1, they progressively desensitized to subsequent GLP-1 stimuli, as evidenced by cellular cAMP production. This GLP-1-induced desensitization did not occur when the incretin was only present during three periods of 1 h at 10 mM glucose that alternated with 6-9 h culture at 3 mM glucose. After these 24h, the beta cells exhibited the same secretory response to glucose (10 mM) and GLP-1 (10 nM at 10 mM glucose), whether GLP-1 was present during the pulses or not. Similarly the presence of 1 nM GIP during these one hour pulses did not influence subsequent secretory responses to glucose and GLP-1. However, when both GLP-1 and GIP, each at 0.5 nM, were added to the one hour pulses, they not only amplified insulin release during the pulses, as was the case with their single addition, but also increased the secretory response to a subsequent stimulation by glucose and GLP-1. These data distinguish between a desensitization effect of a prolonged exposure to GLP-1 and a positive priming effect of a discontinuous exposure to a combination of GLP-1 plus GIP. They may have to be taken into account in drug treatment strategies aiming the mimicking of physiologic patterns in the regulation of insulin release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183115     DOI: 10.1016/j.bcp.2004.02.035

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Regulation of microRNA-375 by cAMP in pancreatic β-cells.

Authors:  David M Keller; Elizabeth A Clark; Richard H Goodman
Journal:  Mol Endocrinol       Date:  2012-04-25

2.  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

Authors:  Helga Ellingsgaard; Irina Hauselmann; Beat Schuler; Abdella M Habib; Laurie L Baggio; Daniel T Meier; Elisabeth Eppler; Karim Bouzakri; Stephan Wueest; Yannick D Muller; Ann Maria Kruse Hansen; Manfred Reinecke; Daniel Konrad; Max Gassmann; Frank Reimann; Philippe A Halban; Jesper Gromada; Daniel J Drucker; Fiona M Gribble; Jan A Ehses; Marc Y Donath
Journal:  Nat Med       Date:  2011-10-30       Impact factor: 53.440

3.  Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?

Authors:  Abdulzahra Hussain; Hind Mahmood; Shamsi El-Hasani
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

4.  Exendin-4 does not promote Beta-cell proliferation or survival during the early post-islet transplant period in mice.

Authors:  M F Crutchlow; M Yu; Y-S Bae; S Deng; D A Stoffers
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

Review 5.  Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal.

Authors:  Simon A Hinke; Karine Hellemans; Frans C Schuit
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

6.  A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice.

Authors:  Victor A Gault; Vikas K Bhat; Nigel Irwin; Peter R Flatt
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

7.  Prolactin receptors and placental lactogen drive male mouse pancreatic islets to pregnancy-related mRNA changes.

Authors:  Lotte Goyvaerts; Katleen Lemaire; Ingrid Arijs; Julien Auffret; Mikaela Granvik; Leentje Van Lommel; Nadine Binart; Peter in't Veld; Frans Schuit; Anica Schraenen
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 8.  The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.

Authors:  David S Mathiesen; Jonatan I Bagger; Natasha C Bergmann; Asger Lund; Mikkel B Christensen; Tina Vilsbøll; Filip K Knop
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

Review 9.  Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment.

Authors:  Maria Chiara Pelle; Michele Provenzano; Isabella Zaffina; Roberta Pujia; Federica Giofrè; Stefania Lucà; Michele Andreucci; Angela Sciacqua; Franco Arturi
Journal:  Life (Basel)       Date:  2021-12-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.